| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
59,420,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Generation Bio is a genetic medicines company providing durable, redosable treatments for potentially various of patients living with rare and prevalent diseases. Co.'s non-viral genetic medicine platform incorporates its DNA construct called closed-ended DNA; its cell-targeted lipid nanoparticle delivery system; and its capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, to produce ceDNA. Using Co.'s platform, it is developing genetic medicines to provide targeted delivery of genetic payloads that include large and multiple genes to a range of cell types across a range of diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
551,455 |
551,455 |
642,217 |
| Total Buy Value |
$0 |
$778,895 |
$778,895 |
$1,265,385 |
| Total People Bought |
0 |
4 |
4 |
4 |
| Total Buy Transactions |
0 |
7 |
7 |
12 |
| Total Shares Sold |
0 |
4,890 |
11,122 |
27,899 |
| Total Sell Value |
$0 |
$7,922 |
$39,768 |
$125,583 |
| Total People Sold |
0 |
2 |
2 |
2 |
| Total Sell Transactions |
0 |
2 |
4 |
10 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
• – – |
2022-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,876 |
14,876 |
|
- |
|
| Kerr Douglas |
CHIEF MEDICAL OFFICER |
• – – |
2022-07-15 |
4 |
D |
$7.18 |
$31,355 |
D/D |
(4,367) |
339,547 |
|
- |
|
| Kerr Douglas |
CHIEF MEDICAL OFFICER |
• – – |
2022-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,876 |
343,914 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2022-07-15 |
4 |
D |
$7.18 |
$31,355 |
D/D |
(4,367) |
208,663 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2022-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,876 |
213,030 |
|
- |
|
| Mcdonough Geoff |
PRESIDENT AND CEO |
• • – |
2022-07-15 |
4 |
D |
$7.18 |
$101,597 |
D/D |
(14,150) |
1,209,286 |
|
- |
|
| Mcdonough Geoff |
PRESIDENT AND CEO |
• • – |
2022-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,876 |
1,223,436 |
|
- |
|
| Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2022-07-15 |
4 |
D |
$7.18 |
$31,355 |
D/D |
(4,367) |
10,509 |
|
- |
|
| Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2022-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,876 |
14,876 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2022-07-15 |
4 |
D |
$7.18 |
$17,390 |
D/D |
(2,422) |
7,438 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2022-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,250 |
9,860 |
|
- |
|
| Nicholson Donald William |
|
– • – |
2022-03-10 |
4 |
B |
$4.71 |
$38,273 |
D/D |
8,126 |
113,576 |
0.01 |
- |
|
| Nicholson Donald William |
|
– • – |
2022-03-09 |
4 |
B |
$4.79 |
$10,983 |
D/D |
2,293 |
105,450 |
0.01 |
- |
|
| Quinn Anthony |
|
– • – |
2021-10-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
72,837 |
72,837 |
|
- |
|
| Quinn Anthony |
|
– • – |
2021-10-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
72,837 |
0 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-09-29 |
4 |
AS |
$24.59 |
$738 |
I/I |
(30) |
608 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-09-29 |
4 |
AS |
$24.59 |
$407,112 |
D/D |
(16,556) |
0 |
|
- |
|
| Rhodes Jason P |
Director |
– • – |
2021-09-29 |
4 |
AS |
$24.59 |
$407,850 |
I/I |
(16,586) |
608 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-09-28 |
4 |
AS |
$25.24 |
$606 |
I/I |
(24) |
638 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-09-28 |
4 |
AS |
$25.24 |
$330,366 |
D/D |
(13,089) |
16,556 |
|
- |
|
| Rhodes Jason P |
Director |
– • – |
2021-09-28 |
4 |
AS |
$25.24 |
$330,972 |
I/I |
(13,113) |
638 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-09-27 |
4 |
AS |
$25.70 |
$2,442 |
I/I |
(95) |
662 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-09-27 |
4 |
AS |
$25.70 |
$1,318,256 |
D/D |
(51,294) |
29,645 |
|
- |
|
| Rhodes Jason P |
Director |
– • – |
2021-09-27 |
4 |
AS |
$25.70 |
$1,320,697 |
I/I |
(51,389) |
662 |
|
- |
|
| Rhodes Jason P |
Director |
– • – |
2021-09-24 |
4 |
AS |
$25.84 |
$747,161 |
I/I |
(28,916) |
757 |
|
- |
|
293 Records found
|
|
Page 6 of 12 |
|
|
